Close Menu

NEW YORK – LifeSpan BioSciences said this week that it has acquired Everest Biotech, which specializes in the production of antigen affinity purified goat polyclonal antibodies. The acquisition will expand LSBio's offering of more than 500,000 monoclonal and polyclonal primary antibodies, the company said. Financial terms of the acquisition were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

23andMe has a holiday popup shop at a mall and could open additional stores, Bloomberg reports.

By studying koalas and a retrovirus that infects them, researchers may have uncovered a new sort of 'immune response' that occurs at the genomic level, Agence France Presse reports.

NPR reports that the first person in the US given a gene editing-based therapy for a genetic disorder is heading home.

In Science this week: ancient genomes reveal social inequality within individual households, new method for quantifying genetic variation in gene dosage, and more.